• Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

  • Feb 12 2024
  • Duración: 32 m
  • Podcast

Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes:

    • Beneficial effects beyond glycemic control 
    • Adverse events and how to manage them
    • Non- or partial responders and the importance of setting expectations with patients 
    • Weight rebound when discontinuing therapy
    • Medication access issues related to cost and drug availability 

    Presenters:

    Jennifer Green, MD
    Professor of Medicine
    Division of Endocrinology and Duke Clinical Research Institute
    Duke University School of Medicine
    Durham, North Carolina

    Carol Hatch Wysham, MD
    Clinical Professor of Medicine
    Clinical Endocrinologist
    MultiCare/Rockwood Clinic
    Spokane, Washington

    Link to online program: 
    https://bit.ly/48b6XnW
    Más Menos
activate_Holiday_promo_in_buybox_DT_T2
Más Menos

Lo que los oyentes dicen sobre Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles